英文摘要 |
Extremely low-birth-weight (ELBW) infants are at a high risk for necrotizing enterocolitis (NEC), which recommends human milk as the priority nutritional choice. Especially, preterm milk contains higher levels of immune protective factors compared with milk from mothers delivering at term. Unfortunately, the clinical instability precludes enteral feedings on the first days after birth for ELBW infants, whereas previous studies explored the alternative methods for oropharyngeal mother's colostrum administration. The study aimed to perform a systematic review of randomized controlled trials and cohort studies to summarize the effects of oropharyngeal mother's colostrum administration on the immunologic effects and growth of ELBW infants. This review focused on the studies published between Jan 1998 and Nov 2018. The following databases were searched: PubMed, The Cochrane Library, MEDLINE, ProQuest, and Airiti Library. Seven studies met the inclusion criteria. Inconsistent results showed that the oropharyngeal mother's colostrum administration may provide a number of benefits for ELBW infants. These benefits include increased secretory immunoglobulin A, lactoferrin, and improved sepsis and NEC. Specifically, single reports have shown that oropharyngeal mother's colostrum administration may increase the rate of breast milk feeding through discharge, earlier attainment of full enteral feeds and oral feeds, improved growth, and influenced the colonization of the oral cavity. Oropharyngeal mother's colostrum administration could be used as a reference for clinical practice in attending to ELBW infants. Additional large and rigorous studies need to verify these results. |